Literature DB >> 10077477

Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers.

J D Reuter1, A Myc, M M Hayes, Z Gan, R Roy, D Qin, R Yin, L T Piehler, R Esfand, D A Tomalia, J R Baker.   

Abstract

Multiple sialic acid (SA) residues conjugated to a linear polyacrylamide backbone are more effective than monomeric SA at inhibiting influenza-induced agglutination of red blood cells. However, "polymeric inhibitors" based on polyacrylamide backbones are cytotoxic. Dendritic polymers offer a nontoxic alternative to polyacrylamide and may provide a variety of potential synthetic inhibitors of influenza virus adhesion due to the wide range of available polymer structures. We evaluated several dendritic polymeric inhibitors, including spheroidal, linear, linear-dendron copolymers, comb-branched, and dendrigraft polymers, for the ability to inhibit virus hemagglutination (HA) and to block infection of mammalian cells in vitro. Four viruses were tested: influenza A H2N2 (selectively propagated two ways), X-31 influenza A H3N2, and sendai. The most potent of the linear and spheroidal inhibitors were 32-256-fold more effective than monomeric SA at inhibiting HA by the H2N2 influenza virus. Linear-dendron copolymers were 1025-8200-fold more effective against H2N2 influenza, X-31 influenza, and sendai viruses. The most effective were the comb-branched and dendrigraft inhibitors, which showed up to 50000-fold increased activity against these viruses. We were able to demonstrate significant (p < 0.001) dose-dependent reduction of influenza infection in mammalian cells by polymeric inhibitors, the first such demonstration for multivalent SA inhibitors. Effective dendrimer polymers were not cytotoxic to mammalian cells at therapeutic levels. Of additional interest, variation in the inhibitory effect was observed with different viruses, suggesting possible differences due to specific growth conditions of virus. SA-conjugated dendritic polymers may provide a new therapeutic modality for viruses that employ SA as their target receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077477     DOI: 10.1021/bc980099n

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  36 in total

1.  Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.

Authors:  H Yoo; R L Juliano
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Monodisperse protein-based glycopolymers via a combined biosynthetic and chemical approach.

Authors:  Ying Wang; Kristi L Kiick
Journal:  J Am Chem Soc       Date:  2005-11-30       Impact factor: 15.419

Review 3.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

4.  Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells.

Authors:  Ja Hye Myung; Khyati A Gajjar; Jelena Saric; David T Eddington; Seungpyo Hong
Journal:  Angew Chem Int Ed Engl       Date:  2011-10-19       Impact factor: 15.336

5.  Nanostructured glycan architecture is important in the inhibition of influenza A virus infection.

Authors:  Seok-Joon Kwon; Dong Hee Na; Jong Hwan Kwak; Marc Douaisi; Fuming Zhang; Eun Ji Park; Jong-Hwan Park; Hana Youn; Chang-Seon Song; Ravi S Kane; Jonathan S Dordick; Kyung Bok Lee; Robert J Linhardt
Journal:  Nat Nanotechnol       Date:  2016-10-24       Impact factor: 39.213

Review 6.  Design and creativity in synthesis of multivalent neoglycoconjugates.

Authors:  Yoann M Chabre; René Roy
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

7.  In quest of a systematic framework for unifying and defining nanoscience.

Authors:  Donald A Tomalia
Journal:  J Nanopart Res       Date:  2009-05-26       Impact factor: 2.253

8.  A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.

Authors:  Che C Colpitts; Luis M Schang
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

9.  Manipulation of electrostatic and saccharide linker interactions in the design of efficient glycopolypeptide-based cholera toxin inhibitors.

Authors:  Ronak Maheshwari; Eric A Levenson; Kristi L Kiick
Journal:  Macromol Biosci       Date:  2010-01-11       Impact factor: 4.979

10.  Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans.

Authors:  Fátima Lasala; Eva Arce; Joaquín R Otero; Javier Rojo; Rafael Delgado
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.